Asfar Sohail Azmi

Targets

• KRAS 2
• EZH2 1
• MDM2 1
• TP53 1

Filled chips are declared by the researcher; the others come from publications (number of works).

Now

Trials, publications and grants since Nov 2024.

• Publication

  Proliferating Cell Nuclear Antigen as New Therapeutic Target in Multiple Myeloma.

  Molecular cancer therapeutics, Oct 2026

• Publication

  Daraxonrasib in pancreatic cancer: When progress disrupts practice.

  Drug discovery today, Aug 2026

• Publication

  Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges.

  Signal transduction and targeted therapy, Nov 2025

• Preprint

  Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma.

  bioRxiv : the preprint server for biology, Nov 2025

• Publication

  An Update on Novel Pharmacotherapies for the Treatment of Neuroendocrine Tumors.

  International journal of molecular sciences, Nov 2025

Affiliations

• The Barbara Ann Karmanos Cancer Institute

Co-authors

Who links you

Enter another researcher's profile link or ID to see who has published with both of you.